By monitoring citrullinated proteins—and then the citrullinated-vimentin-specific levels—in lysates from PBMCs of SLE patients, we observed a significant decrease in protein citrullination after BLM therapy. The gene discussed is VIM; the disease is systemic lupus erythematosus.